DI TARANTO, RAFFAELE
DI TARANTO, RAFFAELE
Dipartimento di Scienze Cliniche e di Comunità
Mostra
records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.004 secondi).
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events
2023 E.G. Favalli, G. Cincinelli, S. Germinario, R. Di Taranto, F. Orsini, G. Maioli, M. Biggioggero, M. Ferrito, R. Caporali
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study
2023 C. Crotti, R. Di Taranto, F. Orsini, M. Ferrito, M. Varenna, E.G. Favalli, R. Caporali
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
2023 M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali
A case report of monoarthritis in a COVID-19 patient and literature review: Simple actions for complex times
2021 G. Cincinelli, R. Di Taranto, F. Orsini, A. Rindone, A. Murgo, R. Caporali
COVID-19 related poor mental health and sleep disorders in rheumatic patients: a citizen science project
2021 F. Ingegnoli, M. Buoli, C. Posio, R. Di Taranto, A. Lo Muscio, E. Cumbo, S. Ostuzzi, R. Caporali